Skip to main content
Circulation Reports logoLink to Circulation Reports
. 2020 Nov 10;2(11):705. doi: 10.1253/circrep.CR-66-0007

Cardioprotective Effects of Rivaroxaban on Cardiac Remodeling After Experimental Myocardial Infarction in Mice

Nobuhiro Nakanishi, Koichi Kaikita , Masanobu Ishii, Yu Oimatsu, Tatsuro Mitsuse, Miwa Ito, Kenshi Yamanaga, Koichiro Fujisue, Hisanori Kanazawa, Daisuke Sueta, Seiji Takashio, Yuichiro Arima, Satoshi Araki, Taishi Nakamura, Kenji Sakamoto, Satoru Suzuki, Eiichiro Yamamoto, Hirofumi Soejima, Kenichi Tsujita
PMCID: PMC7943291  PMID: 33981907

The authors apologize for the written mistakes in the Result section; previous line graphs in Figure 2 showed mean ± 2 standard error (SE). We corrected line graphs in Figure 2 with mean ± SE. Corrections are shown below.

Page 159, Figure 2

Figure 2.

Figure 2.

Effect of rivaroxaban on left ventricular (LV) remodeling after myocardial infarction (MI). Changes in (A) LV end-diastolic diameter (LVDd), (B) LV systolic dimension (LVDs), (C) M-mode percent fractional shortening (%FS), (D) interventricular septum thickness in diastole (IVSTd), and (E) posterior LV wall thickness in diastole (PLWTd)assessed by echocardiography before and at days 1, 7 and 14 after MI in the rivaroxaban and vehicle groups (n=35/group). Data are mean ± standard error. *P<0.05 vs. vehicle.


Articles from Circulation Reports are provided here courtesy of The Japanese Circulation Society

RESOURCES